The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. 1986

L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol

The nucleotide sequence of crossover sites in the genome of four intertypic (type 3/type 1) poliovirus recombinants has been determined. The approximate boundaries of the crossover regions were first estimated by RNase T1 oligonucleotide mapping of the recombinant genomes; then appropriate regions were sequenced by the chain termination method using oligonucleotide-primed reverse transcription of the recombinant RNAs. The crossover sites (defined as the contiguous sequences shared by the recombinant and both parental genomes flanked, in the recombinant genome, by heterotypic RNA segments) are 5, 5, 7, and 11 nucleotides long, respectively. The recombination was precise and was not accompanied by any other genetic alterations. The recombination sites were found to be located within genome segments having a potential to form secondary structure elements. Based on this observation, a model of recombination between picornaviral RNA genomes has been proposed. The essence of this model consists in bringing together homologous regions of two recombining RNA genomes via formation of intermolecular duplexes, detachment of the nascent 3' end of the newly synthesized complementary RNA from a "parting" site on the first template and its subsequent "jumping" to the identical (or closely related) "anchoring" site on the other template. Features of this model are discussed in some detail.

UI MeSH Term Description Entries
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D017955 Poliovirus A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection. Brunhilde Virus,Human poliovirus 1,Human poliovirus 2,Human poliovirus 3,Lansing Virus,Leon Virus,Poliovirus Type 1,Poliovirus Type 2,Poliovirus Type 3,Polioviruses

Related Publications

L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
July 1981, Virology,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
November 1984, Virology,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
November 1983, Virology,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
March 1986, Journal of virology,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
January 1988, Molekuliarnaia biologiia,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
January 1983, Virology,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
December 1988, Nucleic acids research,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
December 2010, PloS one,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
January 1991, SAAS bulletin, biochemistry and biotechnology,
L I Romanova, and V M Blinov, and E A Tolskaya, and E G Viktorova, and M S Kolesnikova, and E A Guseva, and V I Agol
January 1979, Cold Spring Harbor symposia on quantitative biology,
Copied contents to your clipboard!